These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5459676)

  • 1. [Differentiation between pathogenic and nonpathogenic mycobacteria of group II and group 3 by susceptibility to ethambutol].
    Tsukamura M
    Kekkaku; 1970 Aug; 45(8):237-40. PubMed ID: 5459676
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differentiation between Mycobacterium malmoense and Mycobacterium nonchromogenicum by ethambutol susceptibility].
    Yamori S; Tsukamura M
    Kekkaku; 1989 Feb; 64(2):95-7. PubMed ID: 2733305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Number of rifampicin- and ethambutol-resistant variants in strains of atypical mycobacteria pathogenic for man, on Loewenstein-Jensen media].
    Le Lirzin M; Boisvert H
    Ann Inst Pasteur (Paris); 1971 Apr; 120(4):549-59. PubMed ID: 5564197
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ethambutol-sensitivity of mycobacteria].
    Lucchesi M; Termine A; Mancini P
    Ann Ist Carlo Forlanini; 1969; 29(1):51-9. PubMed ID: 4996682
    [No Abstract]   [Full Text] [Related]  

  • 5. [Susceptibility of various mycobacteria to ethambutol--with reference to the differentiation between M. avium and M. terrae].
    Mizuno S; Toyama H; Tsukamura M
    Nihon Saikingaku Zasshi; 1966 Nov; 21(11):672-4. PubMed ID: 6010588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity examination of mycobacteria to ethambutol by using the vertical diffusion test].
    Kalich R
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):107-11. PubMed ID: 5197893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antituberculous activity of cyclic analogs of ethambutol].
    Crémieux A; Baghdadi N; Berthelot P; Debaert M
    Ann Microbiol (Paris); 1983; 134A(2):177-82. PubMed ID: 6870086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exogenous fatty acids on ethambutol susceptibility of sensitive and resistant Mycobacterium smegmatis ATCC 607.
    Cheema S; Asotra S; Khuller GK
    Indian J Exp Biol; 1987 Apr; 25(4):230-2. PubMed ID: 3653931
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of amino acid uptake and susceptibility to ethambutol (EMB) with phospholipid composition of EMB-sensitive and EMB-resistant strains of Mycobacterium smegmatis.
    Cheema S; Asotra S; Khuller GK
    Indian J Exp Biol; 1986 Nov; 24(11):705-9. PubMed ID: 3570371
    [No Abstract]   [Full Text] [Related]  

  • 10. Phospholipid composition and ethambutol sensitivity of Mycobacterium smegmatis ATCC 607.
    Cheema S; Khuller GK
    Indian J Exp Biol; 1985 Sep; 23(9):511-3. PubMed ID: 3833694
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity of atypic mycobacteria to rifampicin and ethambutol].
    Makarevitch NM
    G Ital Chemioter; 1972; 19(2):23-5. PubMed ID: 4666006
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of Mycobacterium phlei of differentiated resistance for the detection of ethambutol and capreomycin in the sera of tuberculous patients].
    Zwolska-Kwiek Z
    Gruzlica; 1972 May; 40(5):411-8. PubMed ID: 4113117
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality control of culture media for mycobacterium drug sensitivity tests].
    Kekkaku; 2003 Aug; 78(8):563-8. PubMed ID: 14582504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atypical mycobacteria].
    Demoulin-Brahy L
    Acta Tuberc Pneumol Belg; 1972; 63(4):397-8. PubMed ID: 4670006
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures.
    Syre H; Valvatne H; Sandven P; Grewal HM
    J Antimicrob Chemother; 2006 May; 57(5):987-91. PubMed ID: 16524896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
    Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
    J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.